Anticancer agent 358
Anticancer agent 358 is a PARP inhibitor with antiproliferative activity against lung cancer cells and low toxicity to normal hepatocytes. Anticancer agent 358 binds to the active site of PARP via hydrogen bonds and π-π interactions with key residues, thereby promoting the accumulation of DNA damage. Anticancer agent 358 induces DNA damage, apoptosis, and autophagy in lung cancer cells. Anticancer agent 358 can be used for the research of non-small cell lung cancer.
For research use only. We do not sell to patients.
- CAS No.: 3087062-38-9
- Formula: C31H27FN6O2S
- Molecular Weight:566.65
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| A549 | IC50 |
13.87 μM
|
Antiproliferative activity against human A549 lung cancer cells assessed as reduction in cell viability incubated for 72 hrs by CCK-8 assay.
Antiproliferative activity against human A549 lung cancer cells assessed as reduction in cell viability incubated for 72 hrs by CCK-8 assay.
|
42481535 |
| PC-9 | IC50 |
3.81 μM
|
Antiproliferative activity against human PC-9 lung cancer cells assessed as reduction in cell viability incubated for 72 hrs by CCK-8 assay.
Antiproliferative activity against human PC-9 lung cancer cells assessed as reduction in cell viability incubated for 72 hrs by CCK-8 assay.
|
42481535 |
| NCI-H460 | IC50 |
10.01 μM
|
Antiproliferative activity against human H460 lung cancer cells assessed as reduction in cell viability incubated for 72 hrs by CCK-8 assay.
Antiproliferative activity against human H460 lung cancer cells assessed as reduction in cell viability incubated for 72 hrs by CCK-8 assay.
|
42481535 |
In Vitro
Anticancer agent 358 (compound 14 h) (10-80 μM; 72 h) potently inhibits the proliferation of A549, PC-9, H460, and H1299 human lung cancer cells with IC50 values of 13.87 μM, 3.81 μM, 10.01 μM, and minimal cytotoxicity against normal L02 liver cells[1].
Anticancer agent 358 (5-20 μM; 24 h) induces dose-dependent cell death in A549, PC-9, and H460 human lung cancer cells, with a particularly pronounced effect in PC-9 cells[1].
Anticancer agent 358 (5-20 μM; 24 h) induces significant DNA damage in A549, PC-9, and H460 human lung cancer cells[1].
Anticancer agent 358 effectively binds to the active site of the PARP protein through key hydrogen bonding and π-π stacking interactions, suggesting potential PARP inhibition activity[1].
Anticancer agent 358 (5-20 μM; 72 h) promotes apoptosis in A549 and H460 human lung cancer cells but does not significantly induce apoptosis in PC-9 human lung cancer cells[1].
Anticancer agent 358 (5-20 μM; 72 h) upregulates the expression of key proteins involved in DNA damage and apoptosis, including caspase-9, γH2AX, and PARP, in A549, PC-9, and H460 human lung cancer cells[1].
Anticancer agent 358 (5-20 μM; 24 h) induces dose-dependent autophagy in A549, PC-9, and H460 human lung cancer cells[1].
Anticancer agent 358 (5-20 μM; 72 h) modulates the expression of key genes involved in DNA damage response, oxidative stress, apoptosis, and autophagy in a cell line-specific manner, with significant upregulation of p21, Bcl-2, caspase-6, Keap1, and ATG7 in H460 human lung cancer cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:A549, PC-9, H460, H1299, L02
-
Concentration:10 μM; 20; 40 μM; 80 μM
-
Incubation Time:72 h
-
Result:Reduced relative cell viability to 42.71% for A549, 43.14% for PC-9, 17.54% for H460, 71.74% for H1299, and above 70% for L02 at 20 μM.
Achieved IC50 values of 13.87 μM (A549), 3.81 μM (PC-9), and 10.01 μM (H460).
-
Cell Line:A549, PC-9, H460
-
Concentration:10-20 μM (A549); 5-10 μM (PC-9, H460)
-
Incubation Time:72 h
-
Result:Elevated apoptotic rate to 5.80% in A549 cells and 28.43% in H460 cells, compared to 3.19% and 15.81% in respective control groups.
Showed no significant change in apoptotic rate in PC-9 cells relative to controls.
-
Cell Line:A549, PC-9, H460
-
Concentration:10-20 μM (A549); 5-10 μM (PC-9, H460)
-
Incubation Time:24 h
-
Result:Increased the number of MDC-positive puncta (autophagosomes) in a dose-dependent manner across all tested cell lines.
-
Cell Line:A549, PC-9, H460
-
Concentration:10-20 μM (A549); 5-10 μM (PC-9, H460)
-
Incubation Time:72 h
-
Result:Differentially modulated gene expression in a cell line-specific manner.
Significantly upregulated the expression of p21, Bcl-2, caspase-6, Keap1, and ATG7 genes in H460 cells.
-
Cell Line:A549, PC-9, H460
-
Concentration:10-20 μM (A549); 5-10 μM (PC-9, H460)
-
Incubation Time:72 h
-
Result:Increased the expression of caspase-9, γH2AX, and PARP proteins in A549, PC-9, and H460 cells.
Chemical Information
-
CAS No. 3087062-38-9
-
Molecular Weight 566.65
-
Formula C31H27FN6O2S
-
SMILES
O=C(C1=C(C)N=C(C2=CC=C(OCC(C)C)C(C#N)=C2)S1)NC3=CC=C(C4=CN(CC5=CC=C(F)C=C5)N=N4)C=C3
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
Autophagy
Autophagy is a process in which eukaryotic cells use lysosomes to degrade their own cytoplasmic proteins and damaged organelles under the regulation of autophagy related gene (Atg). Microtubule-associated proteins light chain 3 (LC3) is recognized as autophagy marker, which transfers from cytoplasmic LC3 (LC3-I) to membrane type (LC3-II). LC3-II/I ratio could be detected by Western Blot and fluorescence microscopy.
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
-
Lysosome and acidic-vesicle live-cell staining
Lysosome and acidic-vesicle live-cell staining detects acidic intracellular compartments by using membrane-permeant acidotropic probes that accumulate in low-pH vesicles, including lysosomes, late endosomes, autolysosomes, and acidic phagosomes. LysoTracker staining is commonly used as an intensity-based readout of acidic lysosomal compartment abundance or enlargement, while acridine orange produces green fluorescence in less concentrated compartments and red fluorescence after concentration-dependent accumulation in acidic vesicular organelles. Loss or reduction of acridine-orange red signal can be used as a readout of lysosomal membrane permeabilization or reduced acidic-vesicle integrity. This protocol is designed for live cultured cells and can be adapted for fluorescence microscopy, high-content imaging, plate-reader readout, or flow cytometry when the selected literature supports the readout. Because these dyes report acidotropic accumulation rather than lysosome identity alone,
-
Macroautophagy Solutions
Macroautophagy is a conserved lysosome-dependent degradation pathway in which cytoplasmic material is sequestered into double-membrane autophagosomes and delivered to lysosomes for degradation and recycling. The pathway supports cellular homeostasis during nutrient limitation, organelle stress, protein-aggregate accumulation, infection, differentiation, and tissue remodeling by coupling cargo sequestration, autophagosome maturation, lysosomal fusion, and degradation of cargo-derived macromolecules. The core molecular sequence includes initiation by nutrient- and stress-regulated autophagy machinery, autophagosome nucleation, LC3/ATG8-family conjugation to autophagosomal membranes, cargo selection through receptors such as SQSTM1/p62, autophagosome-lysosome fusion, and lysosomal degradation. LC3 was identified as a mammalian homolog of yeast Atg8 that localizes to autophagosomal membranes after processing, and p62/SQSTM1 was shown to connect ubiquitinated cargo with autophagic degradati
-
Genotoxicity/Mutagenicity Study
The bacterial reverse mutation assay detects point mutations that restore amino-acid prototrophy in auxotrophic Salmonella typhimurium or Escherichia coli tester strains; after exposure to a test article, mutagenic activity is read out as an increased number of revertant colonies on minimal agar compared with the vehicle control. The assay uses tester strains with different mutation targets so that base-substitution and frameshift mutagens can be detected, and testing is performed with and without exogenous mammalian metabolic activation because some chemicals require biotransformation to become mutagenic.
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)